Psychopharmacology

Papers
(The median citation count of Psychopharmacology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Cannabidiol: pharmacology and therapeutic targets160
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials97
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants85
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats63
Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada60
Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives58
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review56
Serotonin toxicity of serotonergic psychedelics52
7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer’s disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance51
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world49
(R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation45
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research44
Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review39
The acute effects of classic psychedelics on memory in humans39
The zebrafish (Danio rerio) anxiety test battery: comparison of behavioral responses in the novel tank diving and light–dark tasks following exposure to anxiogenic and anxiolytic compounds38
Expectancy in placebo-controlled trials of psychedelics: if so, so what?37
Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults36
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review36
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia36
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions36
Treatment of opioid overdose: current approaches and recent advances36
Pharmacokinetic and pharmacodynamic properties of aerosolized (“vaped”) THC in adolescent male and female rats35
A buprenorphine-validated rat model of opioid use disorder optimized to study sex differences in vulnerability to relapse35
Geniposide ameliorates chronic unpredictable mild stress induced depression-like behavior through inhibition of ceramide-PP2A signaling via the PI3K/Akt/GSK3β axis33
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants32
Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine32
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review31
Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study31
Animal models of chemotherapy-induced cognitive decline in preclinical drug development31
Developing a real-world evidence base for prescribed cannabis in the United Kingdom: preliminary findings from Project Twenty2130
RETRACTED ARTICLE: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy30
Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations30
Sodium butyrate ameliorates the cognitive impairment of Alzheimer’s disease by regulating the metabolism of astrocytes29
Aversion-resistant fentanyl self-administration in mice28
Escalation and reinstatement of fentanyl self-administration in male and female rats28
Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies27
Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products27
The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits26
Ketamine induces rapid antidepressant effects via the autophagy-NLRP3 inflammasome pathway26
Safety pharmacology of acute LSD administration in healthy subjects25
Characterization of operant social interaction in rats: effects of access duration, effort, peer familiarity, housing conditions, and choice between social interaction vs. food or remifentanil25
Cannabidiol (CBD) as a novel treatment in the early phases of psychosis25
Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD25
Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence24
Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis23
Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on!® nicotine pouches compared to combustible cigarettes23
The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia23
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT23
MDMA and memory, addiction, and depression: dose-effect analysis22
Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice22
Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine22
Sign- and goal-tracking score does not correlate with addiction-like behavior following prolonged cocaine self-administration22
Females develop features of an addiction-like phenotype sooner during withdrawal than males22
Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study22
The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study21
Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study21
Patterns of brain function associated with cannabis cue-reactivity in regular cannabis users: a systematic review of fMRI studies21
Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents21
Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine21
Neuroprotective phosphatidylserine liposomes alleviate depressive-like behavior related to stroke through neuroinflammation attenuation in the mouse hippocampus21
Xylazine effects on opioid-induced brain hypoxia20
Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement20
Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis20
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice20
Prevalence of obesity and clinical and metabolic correlates in first-episode schizophrenia relative to healthy controls20
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder20
Modulation of heroin intake by ovarian hormones in gonadectomized and intact female rats19
General anesthesia bullies the gut: a toxic relationship with dysbiosis and cognitive dysfunction19
Is addiction a brain disease? A plea for agnosticism and heterogeneity19
Effects of methylphenidate on reinforcement learning depend on working memory capacity19
Evidence of trospium’s ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results19
Anticonvulsant effect of pterostilbene and its influence on the anxiety- and depression-like behavior in the pentetrazol-kindled mice: behavioral, biochemical, and molecular studies18
Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis18
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis18
The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)18
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe18
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment18
H3K9me2 regulation of BDNF expression in the hippocampus and medial prefrontal cortex is involved in the depressive-like phenotype induced by maternal separation in male rats18
Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats17
Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice17
Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology17
Baicalin attenuates amyloid β oligomers induced memory deficits and mitochondria fragmentation through regulation of PDE-PKA-Drp1 signalling17
MicroRNA-31-3p/RhoA signaling in the dorsal hippocampus modulates methamphetamine-induced conditioned place preference in mice17
Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways17
Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use17
Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats17
Combined effect of alcohol and cannabis on simulated driving16
Challenges in CNS drug development and the role of imaging16
Analysis of recreational psychedelic substance use experiences classified by substance16
Fluvoxamine, melatonin and COVID-1916
Astragalin attenuates depression-like behaviors and memory deficits and promotes M2 microglia polarization by regulating IL-4R/JAK1/STAT6 signaling pathway in a murine model of perimenopausal depressi16
Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors16
Role of nucleus accumbens microRNA-181a and MeCP2 in incubation of heroin craving in male rats16
Noradrenergic contributions to cue-driven risk-taking and impulsivity16
Comparison of N-methyl-2-pyrrolidone (NMP) and the “date rape” drug GHB: behavioral toxicology in the mouse model16
Potentiation of cognitive enhancer effects of Alzheimer’s disease medication memantine by alpha7 nicotinic acetylcholine receptor agonist PHA-543613 in the Morris water maze task16
Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder16
Effects of catechin on a rodent model of autism spectrum disorder: implications for the role of nitric oxide in neuroinflammatory pathway15
Altered fronto-occipital connectivity during visual selective attention in regular cannabis users15
Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder15
Sex differences in stress-induced alcohol intake: a review of preclinical studies focused on amygdala and inflammatory pathways15
Apigenin attenuates LPS-induced neurotoxicity and cognitive impairment in mice via promoting mitochondrial fusion/mitophagy: role of SIRT3/PINK1/Parkin pathway15
Loganin ameliorates depression-like behaviors of mice via modulation of serotoninergic system15
Chronic nanocurcumin treatment ameliorates pain-related behavior, improves spatial memory, and reduces hippocampal levels of IL-1β and TNFα in the chronic constriction injury model of neuropathic pain15
Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats15
The GABAB receptor positive allosteric modulator ASP8062 reduces operant alcohol self-administration in male and female Sprague Dawley rats15
Pregnenolone effects on provoked alcohol craving, anxiety, HPA axis, and autonomic arousal in individuals with alcohol use disorder15
Amphetamine alters an EEG marker of reward processing in humans and mice15
Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice15
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?14
The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress14
2-Phenyl-3-(phenylselanyl)benzofuran elicits acute antidepressant-like action in male Swiss mice mediated by modulation of the dopaminergic system and reveals therapeutic efficacy in both sexes14
Alterations in gut microbiota affect behavioral and inflammatory responses to methamphetamine in mice14
The role of microglia in chronic pain and depression: innocent bystander or culprit?14
Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette14
Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway14
Psychopharmacological properties and therapeutic profile of the antidepressant venlafaxine14
Cannabinoids, reward processing, and psychosis14
Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey14
Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder14
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy14
Individual differences in social play behaviour predict alcohol intake and control over alcohol seeking in rats13
Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism13
Resveratrol attenuates arsenic-induced cognitive deficits via modulation of Estrogen-NMDAR-BDNF signalling pathway in female mouse hippocampus13
A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes13
Metabolomics changes in brain-gut axis after unpredictable chronic mild stress13
Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice13
Dopaminergic modulation of reward discounting in healthy rats: a systematic review and meta-analysis13
Behavioral changes and brain epigenetic alterations induced by maternal deficiencies of B vitamins in a mouse model13
Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome13
Temporal analysis of individual ethanol consumption in socially housed mice and the effects of oxytocin13
Smoking-related cue reactivity in a virtual reality setting: association between craving and EEG measures13
Sex differences in specific aspects of two animal tests of anxiety-like behavior13
Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats13
Social isolation at adolescence: a systematic review on behaviour related to cocaine, amphetamine and nicotine use in rats and mice13
Evidence accumulation and associated error-related brain activity as computationally-informed prospective predictors of substance use in emerging adulthood13
Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer’s diseases12
Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis12
Sodium phenylbutyrate reduces repetitive self-grooming behavior and rescues social and cognitive deficits in mouse models of autism12
The role of serotonin neurotransmission in rapid antidepressant actions12
Do psychedelics change beliefs?12
Consistent evidence of indirect effects of impulsive delay discounting and negative urgency between childhood adversity and adult substance use in two samples12
Electroconvulsive seizure inhibits the mTOR signaling pathway via AMPK in the rat frontal cortex12
Effects of the glucocorticoid receptor antagonist PT150 on stress-induced fentanyl seeking in male and female rats12
Glatiramer acetate attenuates depressive/anxiety-like behaviors and cognitive deficits induced by post-weaning social isolation in male mice12
No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers12
Time-dependent regulation of perineuronal nets in the cerebellar cortex during abstinence of cocaine-self administration12
Serotonin 5-HT1B receptors mediate the antidepressant- and anxiolytic-like effects of ventromedial prefrontal cortex deep brain stimulation in a mouse model of social defeat12
Uncovering psychological mechanisms mediating the effects of drugs: some issues and comments using the example of psychedelic drugs12
Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence12
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry12
Sign tracking predicts suboptimal behavior in a rodent gambling task11
Prospecting for a quinoline containing selenium for comorbidities depression and memory impairment induced by restriction stress in mice11
Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study11
Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil11
A role for the circadian transcription factor NPAS2 in the progressive loss of non-rapid eye movement sleep and increased arousal during fentanyl withdrawal in male mice11
Phosphodiesterase inhibitors in psychiatric disorders11
Therapeutic effect of Thymoquinone on behavioural response to UCMS and neuroinflammation in hippocampus and amygdala in BALB/c mice model11
Effects of combined THC and heroin vapor inhalation in rats11
Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice11
A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment11
MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist11
Flavor additives facilitate oral self-administration of nicotine solution in mice11
Evidence of an antidepressant-like effect of xylopic acid mediated by serotonergic mechanisms11
Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial11
Low doses of ketamine and guanosine abrogate corticosterone-induced anxiety-related behavior, but not disturbances in the hippocampal NLRP3 inflammasome pathway11
The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats11
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study11
The cognitive and behavioral effects of D-amphetamine and nicotine sensitization in adult zebrafish11
Plasma gamma-aminobutyric acid (GABA) levels and posttraumatic stress disorder symptoms in trauma-exposed women: a preliminary report11
Individual differences in addiction-like behaviors and choice between cocaine versus food in Heterogeneous Stock rats11
Co-treatment of vitamin D supplementation with enriched environment improves synaptic plasticity and spatial learning and memory in aged rats11
Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram11
The acute effects of alcohol on state rumination in the laboratory11
Long acting aripiprazole influences cognitive functions in recent onset schizophrenia11
Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-γ-dependent regulation of ADPN/FGF9 pathway11
Energizing effects of bupropion on effortful behaviors in mice under positive and negative test conditions: modulation of DARPP-32 phosphorylation patterns10
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis10
Set and setting in microdosing: an oft-overlooked principle10
Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users10
The neurotherapeutic role of a selenium-functionalized quinoline in hypothalamic obese rats10
Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ9-THC)10
The relationship between job stress and job burnout moderated by BDNF rs6265 polymorphism10
Antibiotic exposure and childhood attention-deficit/hyperactivity disorder: systematic review and meta-analysis10
Evaluation of dopamine D3 receptor occupancy by blonanserin using [11C]-(+)-PHNO in schizophrenia patients10
Effects of acute alcohol administration on working memory: a systematic review and meta-analysis10
Samelisant (SUVN-G3031), a potent, selective and orally active histamine H3 receptor inverse agonist for the potential treatment of narcolepsy: pharmacological and neurochemical characterisation10
Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow10
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies10
Peer presence and familiarity as key factors to reduce cocaine intake in both rats and humans: an effect mediated by the subthalamic nucleus10
Involvement of oxidative pathways and BDNF in the antidepressant effect of carvedilol in a depression model induced by chronic unpredictable stress10
Effects of kappa opioid receptor agonists on fentanyl vs. food choice in male and female rats: contingent vs. non-contingent administration10
Do proinflammatory cytokines play a role in clozapine-associated glycometabolism disorders?10
CRF-5-HT interactions in the dorsal raphe nucleus and motivation for stress-induced opioid reinstatement10
Reduced cortical GABA and glutamate in high schizotypy10
Early resource scarcity alters motivation for natural rewards in a sex- and reinforcer-dependent manner10
The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls10
Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?10
Daily, but not occasional, cannabis use is selectively associated with more impulsive delay discounting and hyperactive ADHD symptoms in binge-drinking young adults10
Antipsychotics and risk of QT prolongation: a pharmacovigilance study10
Relationship between voluntary ethanol drinking and approach-avoidance biases in the face of motivational conflict: novel sex-dependent associations in rats10
Intranasal oxytocin decreases self-oriented learning10
The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans10
Novelty-induced locomotor behavior predicts heroin addiction vulnerability in male, but not female, rats10
Targeting neuronal nitric oxide synthase and the nitrergic system in post-traumatic stress disorder10
Duration- and sex-dependent neural circuit control of voluntary physical activity10
Adolescent cocaine induced persistent negative affect in female rats exposed to early-life stress10
Basolateral amygdala and orbitofrontal cortex, but not dorsal hippocampus, are necessary for the control of reward-seeking by occasion setters10
Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose10
The role of the nucleus reuniens in regulating contextual conditioning with the predator odor TMT in female rats9
Cannabinoid receptor GPR55 activation blocks nicotine use disorder by regulation of AMPAR phosphorylation9
Human umbilical cord mesenchymal stem cells ameliorate depression by regulating Jmjd3 and microglia polarization in myocardial infarction mice9
Circulating microRNA miR-137 as a stable biomarker for methamphetamine abstinence9
Respiratory effects of oral mitragynine and oxycodone in a rodent model9
Mitragynine improves cognitive performance in morphine-withdrawn rats9
The selective TAAR1 partial agonist RO5263397 promoted novelty recognition memory in mice9
Diosgenin alleviates alcohol-mediated escalation of social defeat stress and the neurobiological sequalae9
Memory enhancing effects of nicotine, cocaine, and their conditioned stimuli; effects of beta-adrenergic and dopamine D2 receptor antagonists9
Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses9
Endocannabinoid signaling of homeostatic status modulates functional connectivity in reward and salience networks9
Shanzhiside methylester protects against depression by inhibiting inflammation via the miRNA-155-5p/SOCS1 axis9
Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms9
Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats9
“The wrong tools for the right job”: a critical meta-analysis of traditional tests to assess behavioural impacts of maternal separation9
Selenium abates manganese–induced striatal and hippocampal toxicity via abrogation of neurobehavioral deficits, biometal accumulation, oxidative stress, inflammation, and caspase-3 activation in rats9
Opioid-like adverse effects of tianeptine in male rats and mice9
Sex differences in affective states and association with voluntary ethanol intake in Sprague–Dawley rats9
Prenatal exposure to morphine impairs attention and impulsivity in adult rats9
Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits8
Shifts in the neurobiological mechanisms motivating cocaine use with the development of an addiction-like phenotype in male rats8
Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study8
Effects of average reward rate on vigor as a function of individual variation in striatal dopamine8
Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression8
Inhibition of a cortico-thalamic circuit attenuates cue-induced reinstatement of drug-seeking behavior in “relapse prone” male rats8
The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure8
Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance8
Perinatal oxycodone exposure causes long-term sex-dependent changes in weight trajectory and sensory processing in adult mice8
Association between functional brain alterations and neuropsychological scales in male chronic smokers using resting-state fMRI8
Fatty acid amide hydrolase inhibition alleviates anxiety-like symptoms in a rat model used to study post-traumatic stress disorder8
Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial8
Optogenetic manipulation of the prelimbic cortex during fear memory reconsolidation alters fear extinction in a preclinical model of comorbid PTSD/AUD8
The role of CYP2D in rat brain in methamphetamine-induced striatal dopamine and serotonin release and behavioral sensitization8
Low-normal doses of methiopropamine induce aggressive behaviour in mice8
Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice8
Effects of topiramate on the association between affect, cannabis craving, and cannabis use in the daily life of youth during a randomized clinical trial8
Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats8
Mechanism and therapeutic strategies of depression after myocardial infarction8
Involvement of the serotonergic system in the antidepressant-like effect of 1-(phenylselanyl)-2-(p-tolyl)indolizine in mice8
Gut microbiota is involved in the antidepressant effects of adipose-derived mesenchymal stem cells in chronic social defeat stress mouse model8
Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats8
0.05664587020874